Jefferies Adjusts Price Target on Moderna to $215 From $150

Jefferies has raised its price target for Moderna, Inc. (MRNA) from $150 to $215, reflecting an updated analysis of the company's market position and valuation. This adjustment was reported on October 22, 2026.